Curr Med Chem. 2007;14(19):2033-47.

Discovery and development of ATPase inhibitors of DNA gyrase as antibacterial agents.

Source

Lek Pharmaceuticals, D.D., Drug Discovery, Ljubljana, Slovenia. marko.oblak@sandoz.com

Abstract

DNA gyrase is an attractive and well established target for the development of antibacterial agents. This bacterial enzyme, whose biological function is to control the topological state of DNA molecules, consists of two catalytic subunits; GyrA is responsible for DNA breakage and reunion, while the subunit GyrB contains the ATP-binding site. Coumarins and cyclothialidines are natural products that inhibit the ATPase activity of DNA gyrase by blocking the binding of ATP to subunit GyrB. The mechanism of action of these compounds was exhaustively characterized by biochemical methods and supported by protein crystallography. The abundance of crystallographic data on the N-terminal domain of GyrB in its complexes with various ligands has enabled the structure-based design of novel efficient chemotypes as inhibitors of the ATPase domain. This review summarizes the discovery of ATPase inhibitors of DNA gyrase B in the last decade and their development as potential antibacterial agents.

PMID:: 17691945; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Antibiotics - MedlinePlus Health Information

Supplemental Content

Icon for Bentham Science Publishers Ltd.

Save items

Related citations in PubMed

Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships. [J Med Chem. 2008]
Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships.
Charifson PS, Grillot AL, Grossman TH, Parsons JD, Badia M, Bellon S, Deininger DD, Drumm JE, Gross CH, LeTiran A, et al. J Med Chem. 2008 Sep 11; 51(17):5243-63. Epub 2008 Aug 9.
DNA gyrase (GyrB)/topoisomerase IV (ParE) inhibitors: synthesis and antibacterial activity. [Bioorg Med Chem Lett. 2009]
DNA gyrase (GyrB)/topoisomerase IV (ParE) inhibitors: synthesis and antibacterial activity.
East SP, White CB, Barker O, Barker S, Bennett J, Brown D, Boyd EA, Brennan C, Chowdhury C, Collins I, et al. Bioorg Med Chem Lett. 2009 Feb 1; 19(3):894-9. Epub 2008 Dec 3.
Streptococcus pneumononiae gyrase ATPase: development and validation of an assay for inhibitor discovery and characterization. [Anal Biochem. 2007]
Streptococcus pneumononiae gyrase ATPase: development and validation of an assay for inhibitor discovery and characterization.
Miller JR, Herberg JT, Tomilo M, McCroskey MC, Feilmeier BJ. Anal Biochem. 2007 Jun 1; 365(1):132-43. Epub 2007 Feb 27.
Review Mycobacterium tuberculosis DNA gyrase as a target for drug discovery. [Infect Disord Drug Targets. 2007]
Review Mycobacterium tuberculosis DNA gyrase as a target for drug discovery.
Mdluli K, Ma Z. Infect Disord Drug Targets. 2007 Jun; 7(2):159-68.
Review New inhibitors of bacterial topoisomerase GyrA/ParC subunits. [Curr Opin Investig Drugs. 2009]
Review New inhibitors of bacterial topoisomerase GyrA/ParC subunits.
Black MT, Coleman K. Curr Opin Investig Drugs. 2009 Aug; 10(8):804-10.

See reviews... See all...

Cited by 6 PubMed Central articles

Architecture and conservation of the bacterial DNA replication machinery, an underexploited drug target. [Curr Drug Targets. 2012]
Architecture and conservation of the bacterial DNA replication machinery, an underexploited drug target.
Robinson A, Causer RJ, Dixon NE. Curr Drug Targets. 2012 Mar; 13(3):352-72.
Review Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. [Appl Microbiol Biotechnol. 2011]
Review Exploiting bacterial DNA gyrase as a drug target: current state and perspectives.
Collin F, Karkare S, Maxwell A. Appl Microbiol Biotechnol. 2011 Nov; 92(3):479-97. Epub 2011 Sep 9.
A high-throughput fluorescence polarization assay for inhibitors of gyrase B. [J Biomol Screen. 2011]
A high-throughput fluorescence polarization assay for inhibitors of gyrase B.
Glaser BT, Malerich JP, Duellman SJ, Fong J, Hutson C, Fine RM, Keblansky B, Tang MJ, Madrid PB. J Biomol Screen. 2011 Feb; 16(2):230-8. Epub 2011 Jan 18.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Discovery and development of ATPase inhibitors of DNA gyrase as antibacterial ag...
Discovery and development of ATPase inhibitors of DNA gyrase as antibacterial agents.
Curr Med Chem. 2007 ;14(19):2033-47.

PubMed
Energy balance and carcinogenesis: underlying pathways and targets for intervent...
Energy balance and carcinogenesis: underlying pathways and targets for intervention.
Curr Cancer Drug Targets. 2007 Aug ;7(5):484-91.

PubMed
A population balance model describing the cell cycle dynamics of myeloma cell cu...
A population balance model describing the cell cycle dynamics of myeloma cell cultivation.
Biotechnol Prog. 2007 Sep-Oct ;23(5):1198-209. Epub 2007 Aug 11 .

PubMed
Quantification of vitamin E and gamma-oryzanol components in rice germ and bran.
Quantification of vitamin E and gamma-oryzanol components in rice germ and bran.
J Agric Food Chem. 2007 Sep 5 ;55(18):7308-13. Epub 2007 Aug 11 .

PubMed
Comparison of two platelet count estimation methodologies for peripheral blood s...
Comparison of two platelet count estimation methodologies for peripheral blood smears.
Clin Lab Sci. 2007 Summer ;20(3):154-60.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Discovery and development of ATPase inhibitors of DNA gyrase as antibacterial agents.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 6 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information